Roche Diagnostics Leading and creating new markets

More documents

Recommendations

Info

Strong Operational Performance Key Areas of Focus Diagnostics of the Future r Diagnostics 6
Roche Diagnostics Clear market leader Roche Abbott J & J Bayer* Beckman C. Dade Behring IVD Market market share 1 8 % 7 % 6 % 10 % 12 % 20 % 0% 5% 10% 15% 20% -3 % sales growth 2 1 source: company reports, Boston Biomedical Consultants, Roche analysis 2 in local currencies, excludes Life Science research market * based on 2003 results 4 % 4 % 4 % 5 % r 10 % 0% 5% 10% Diagnostics 12% 7
Page 1 and 2: Roche Diagnostics Leading and creat
Page 3 and 4: Roche’s strategic decisions 1990-
Page 5: Roche Diagnostics Well positioned i
Page 9 and 10: 2004: Off to a good start Double ma
Page 11 and 12: Roche Diagnostics Performance r Sig
Page 13 and 14: Strong Operational Performance Key
Page 15 and 16: Broadest product portfolio in the i
Page 17 and 18: Roche is well positioned in growing
Page 19 and 20: Diabetes Care Strategy Focused on t
Page 21 and 22: Two technological approaches Benefi
Page 23 and 24: Substantial Portfolio keeps Roche D
Page 25 and 26: Molecular Diagnostics Roche the und
Page 27 and 28: Market leader in NAT blood screenin
Page 29 and 30: Human Papillomavirus (HPV) New grow
Page 31 and 32: Immunodiagnostics r Gaining market
Page 33 and 34: Introducing The cobas “c” Serie
Page 35 and 36: Health Economics Elecsys ProBNP red
Page 37 and 38: R&D milestone guidelines Idea This
Page 39 and 40: Strong Operational Performance Key
Page 41 and 42: Diagnostics in clinical practice In
Page 43 and 44: 2a. Breast cancer screening High me
Page 45 and 46: 2b. Gene chip for sub-classificatio
Page 47 and 48: 3a. Test to predict recurrence of b
Page 49 and 50: Studies designed to address a numbe
Page 51 and 52: Diagnostics Strategy Stretching our
Page 53 and 54: Value Roche Diagnostic strategic pa

Roche Diagnostics Leading and creating new markets

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?